Reverse cholesterol transport

Biochemistry of Atherosclerosis

Volumn , Issue , 2006, Pages 3-22

  Burgess, Jim W ^a   Sinclair, Philip A ^a   Chretien, Christophe M ^a   Boucher, Jonathon ^b   Sparks, Daniel L ^a,b  

^a Liponex Inc   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

ABCA1; apolipoproteins; bile acids; cholesterol ester transfer protein; high density lipoprotein; lipase; scavenger receptor BI

Indexed keywords

EID: 84886956923     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-36279-3_1     Document Type: Chapter

References (111)

1. Yokoyama S: Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta 1529: 231-244, 2000.
2. Oram JF: Tangier disease and ABCA1. Biochim Biophys Acta 1529: 321-330, 2000.
3. Oram JF, Vaughan AM: ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 11: 253-260, 2000.
4. Wang N, Silver DL, Costet P, Tall AR: Specific binding of apoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275: 33053-33058, 2000.
5. Oram JF, Lawn RM, Garvin MR, Wade DP: ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 275: 34508-34511, 2000.
6. Burgess JW, Frank PG, Franklin V, Liang P, McManus DC, Desforges M, Rassart E, Marcel YL: Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage. Biochemistry 38: 14524-14533, 1999.
7. Burgess JW, Kiss RS, Zheng H, Zachariah S, Marcel YL: Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipopro-tein A-I and participate in ABCA1-dependent cholesterol efflux. J Biol Chem 277: 31318-31326, 2002.
8. Oram JF, Lawn RM: ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 42: 1173-1179, 2001.
9. Nofer JR, Feuerborn R, Levkau B, Sokoll A, Seedorf U, Assmann G: Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J Biol Chem 278: 53055-53062, 2003.
10. Nofer JR, Fobker M, Hobbel G, Voss R, Wolinska I, Tepel M, Zidek W, Junker R, Seedorf U, von Eckardstein A, Assmann G, Walter M: Activation of phos-phatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 39: 15199-15207, 2000.
11. Walter M, Reinecke H, Gerdes U, Nofer JR, Hobbel G, Seedorf U, Assmann G: Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidyl-choline breakdown in HDL-mediated cholesterol efflux mechanisms. J Clin Invest 98: 2315-2323, 1996.
12. Haidar B, Denis M, Marcil M, Krimbou L, Genest J Jr: Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J Biol Chem 279: 9963-9969, 2004.
13. Theret N, Delbart C, Aguie G, Fruchart JC, Vassaux G, Ailhaud G: Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem Biophys Res Commun 173: 1361-1368, 1990.
14. Mendez AJ, Oram JF, Bierman EL: Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 266: 10104-10111, 1991.
15. Tang C, Vaughan AM, Oram JF: Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J Biol Chem 279: 7622-7628, 2004.
16. Yamauchi Y, Chang CC, Hayashi M, Abe-Dohmae S, Reid PC, Chang TY, Yokoyama S: Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts. J Lipid Res 45: 1943-1951, 2004.
17. Yamauchi Y, Hayashi M, Abe-Dohmae S, Yokoyama S: Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J Biol Chem 278: 47890-47897, 2003.
18. Haidar B, Denis M, Krimbou L, Marcil M, Genest J Jr: cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 43: 2087-2094, 2002.
19. See RH, Caday-Malcolm RA, Singaraja RR, Zhou S, Silverston A, Huber MT, Moran J, James ER, Janoo R, Savill JM, Rigot V, Zhang LH, Wang M, Chimini G, Wellington CL, Tafuri SR, Hayden MR: Protein kinase A site-specific phos-phorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospho-lipid efflux. J Biol Chem 277: 41835-41842, 2002.
20. Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, Silver DL, Tall AR: A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 111: 99-107, 2003.
21. Yang XP, Freeman LA, Knapper CL, Amar MJ, Remaley A, Brewer HB Jr, Santamarina-Fojo S: The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene. J Lipid Res 43: 297-306, 2002.
22. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000.
23. Costet P, Lalanne F, Gerbod-Giannone MC, Molina JR, Fu X, Lund EG, Gudas LJ, Tall AR: Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol Cell Biol 23: 7756-7766, 2003.
24. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B: PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7: 53-58, 2001.
25. Panousis CG, Zuckerman SH: Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 20: 1565-1571, 2000.
26. Cabrero A, Cubero M, Llaverias G, Jove M, Planavila A, Alegret M, Sanchez R, Laguna JC, Carrera MV: Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Metabolism 52: 652-657, 2003.
27. Jonas A: Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529: 245-256, 2000.
28. Tall AR: Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 86: 379-384, 1990.
29. Barter PJ, Hopkins GJ, Calvert GD: Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochem J 208: 1-7, 1982.
30. Burgess JW, Boucher J, Neville TA, Rouillard P, Stamler C, Zachariah S, Sparks DL: Phosphatidylinositol promotes cholesterol transport and excretion. J Lipid Res 44: 1355-1363, 2003.
31. Jonas A: Regulation of lecithin cholesterol acyltransferase activity. Prog Lipid Res 37: 209-234, 1998.
32. Gaudet F, Ginsburg GS: Transcriptional regulation of the cholesteryl ester transfer protein gene by the orphan nuclear hormone receptor apolipoprotein AI regulatory protein-1. J Biol Chem 270: 29916-29922, 1995.
33. Agellon LB, Zhang P, Jiang XC, Mendelsohn L, Tall AR: The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter. J Biol Chem 267: 22336-22339, 1992.
34. Jeoung NH, Jang WG, Nam JI, Pak YK, Park YB: Identification of retinoic acid receptor element in human cholesteryl ester transfer protein gene. Biochem Biophys Res Commun 258: 411-415, 1999.
35. Chouinard RA Jr, Luo Y, Osborne TF, Walsh A, Tall AR: Sterol regulatory element binding protein-1 activates the cholesteryl ester transfer protein gene in vivo but is not required for sterol up-regulation of gene expression. J Biol Chem 273: 22409-22414, 1998.
36. Luo Y, Liang CP, Tall AR: The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J Biol Chem 276: 24767-24773, 2001.
37. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall A: Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J Clin Invest 90: 1290-1295, 1992.
38. Hirano R, Igarashi O, Kondo K, Itakura H, Matsumoto A: Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells. Lipids 36: 401-406, 2001.
39. Masucci-Magoulas L, Moulin P, Jiang XC, Richardson H, Walsh A, Breslow JL, Tall A: Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J Clin Invest 95: 1587-1594, 1995.
40. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW: Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364: 73-75, 1993.
41. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR: Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipopro-teins. Nature 342: 448-451, 1989.
42. Miller NE, Nanjee MN: Evidence that reverse cholesterol transport is stimulated by lipolysis of triglyceride-rich lipoproteins. FEBS Lett 285: 132-134, 1991.
43. Navab M, Hama SY, Hough GP, Hedrick CC, Sorenson R, La Du BN, Kobashigawa JA, Fonarow GC, Berliner JA, Laks H, Fogelman AM: High density associated enzymes: their role in vascular biology. Curr Opin Lipidol 9: 449-456, 1998.
44. Coleman T, Seip RL, Gimble JM, Lee D, Maeda N, Semenkovich CF: COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem 270: 12518-12525, 1995.
45. Parrott CL, Alsayed N, Rebourcet R, Santamarina-Fojo S: ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome. J Lipid Res 33: 361-367, 1992.
46. Santamarina-Fojo S, Haudenschild C, Amar M: The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 9: 211-219, 1998.
47. Thuren T: Hepatic lipase and HDL metabolism. Curr Opin Lipidol 11: 277-283, 2000.
48. Soderlund S, Soro-Paavonen A, Ehnholm C, Jauhiainen M, Taskinen MR: Hypertriglyceridemia is associated with prebeta-HDL levels in subjects with familial low HDL. J Lipid Res 2005.
49. Collet X, Tall AR, Serajuddin H, Guendouzi K, Royer L, Oliveira H, Barbaras R, Jiang XC, Francone OL: Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 40: 1185-1193, 1999.
50. Meddings JB, Dietschy JM: Regulation of plasma levels of low-density lipopro-tein cholesterol: interpretation of data on low-density lipoprotein turnover in man. Circulation 74: 805-814, 1986.
51. Ji ZS, Dichek HL, Miranda RD, Mahley RW: Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem 272: 31285-31292, 1997.
52. Williams KJ, Fless GM, Petrie KA, Snyder ML, Brocia RW, Swenson TL: Mechanisms by which lipoprotein lipase alters cellular metabolism of lipopro-tein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem 267: 13284-13292, 1992.
53. Rhainds D, Brissette L: Low density lipoprotein uptake: holoparticle and cho-lesteryl ester selective uptake. Int J Biochem Cell Biol 31: 915-931, 1999.
54. Wang N, Weng W, Breslow JL, Tall AR: Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem 271: 21001-21004, 1996.
55. Lambert G, Chase MB, Dugi K, Brewer J, Santamarina-Fojo S, Bensadoun A, Lambert G: Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J Lipid Res 40: 1294-1303, 1999.
56. Brundert M, Greten H, Rinninger F, Heeren J: Hepatic lipase mediates an increase in selective uptake of HDL-associated cholesteryl esters by cells in culture independent from SR-BI. J Lipid Res 44: 1020-1032, 2003.
57. Connelly MA, Klein SM, Azhar S, Abumrad NA, Williams DL: Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 274: 41-47, 1999.
58. Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M: The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 273: 26338-26348, 1998.
59. Rodrigueza WV, Thuahnai ST, Temel RE, Lund-Katz S, Phillips MC, Williams DL: Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem 274: 20344-20350, 1999.
60. Silver DL, Jiang XC, Arai T, Bruce C, Tall AR: Receptors and lipid transfer proteins in HDL metabolism. Ann NY Acad Sci 902: 103-111, 2000.
61. Pittman RC, Steinberg D: Sites and mechanisms of uptake and degradation of high density and low density lipoproteins. J Lipid Res 25: 1577-1585, 1984.
62. Calvo D, Gomez-Coronado D, Lasuncion MA, Vega MA: CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipopro-teins. Arterioscler Thromb Vasc Biol 17: 2341-2349, 1997.
63. Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA: Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39: 777-788, 1998.
64. Rhainds D, Brodeur M, Lapointe J, Charpentier D, Falstrault L, Brissette L: The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters. Biochemistry 42: 7527-7538, 2003.
65. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, Mozas P, Keilty J, Squazzo S, Woolf EA, Ordovas JM: Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19: 1734-1743, 1999.
66. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol home-ostasis. Science 232: 34-47, 1986.
67. Saucier SE, Kandutsch AA, Gayen AK, Swahn DK, Spencer TA: Oxysterol regulators of 3-hydroxy-3-methylglutaryl-CoA reductase in liver. Effect of dietary cholesterol. J Biol Chem 264: 6863-6869, 1989.
68. Brown MS, Goldstein JL: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96: 11041-11048, 1999.
69. Kumar A, Middleton A, Chambers TC, Mehta KD: Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1beta-and tumor necrosis factor-alpha-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 273: 15742-15748, 1998.
70. Rigotti A, Miettinen HE, Krieger M: The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 24: 357-387, 2003.
71. Bosner MS, Lange LG, Stenson WF, Ostlund RE Jr: Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 40: 302-308, 1999.
72. Sturley SL: Molecular aspects of intracellular sterol esterification: the acyl coen-zyme A: cholesterol acyltransferase reaction. Curr Opin Lipidol 8: 167-173, 1997.
73. Ghosh S, Mallonee DH, Hylemon PB, Grogan WM: Molecular cloning and expression of rat hepatic neutral cholesteryl ester hydrolase. Biochim Biophys Acta 1259: 305-312, 1995.
74. Miller WL, Strauss JF III: Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. J Steroid Biochem Mol Biol 69: 131-141, 1999.
75. van Meer G: Caveolin, cholesterol, and lipid droplets? J Cell Biol 152: F29-F34, 2001.
76. Botham KM, Bravo E: The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models. Prog Lipid Res 34: 71-97, 1995.
77. Russell DW: The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72: 137-174, 2003.
78. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ: The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273: 10046-10050, 1998.
79. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH: Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110: 671-680, 2002.
80. Small DM, Dowling RH, Redinger RN: The enterohepatic circulation of bile salts. Arch Intern Med 130: 552-573, 1972.
81. Chen HC: Molecular mechanisms of sterol absorption. J Nutr 131: 2603-2605, 2001.
82. Repa JJ, Mangelsdorf DJ: Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol 10: 557-563, 1999.
83. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6: 507-515, 2000.
84. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ: Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21: 1393-1403, 2001.
85. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-medi-ated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000.
86. Bocher V, Pineda-Torra I, Fruchart JC, Staels B: PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann NY Acad Sci 967: 7-18, 2002.
87. Hunt MC, Yang YZ, Eggertsen G, Carneheim CM, Gafvels M, Einarsson C, Alexson SE: The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. J Biol Chem 275: 28947-28953, 2000.
88. Malerod L, Sporstol M, Juvet LK, Mousavi A, Gjoen T, Berg T: Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha. Biochem Biophys Res Commun 305: 557-565, 2003.
89. Connelly PW: The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta 286: 243-255, 1999.
90. Dugi KA, Vaisman BL, Sakai N, Knapper CL, Meyn SM, Brewer HB Jr, Santamarina-Fojo S: Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J Lipid Res 38: 1822-1832, 1997.
91. Dugi KA, Amar MJ, Haudenschild CC, Shamburek RD, Bensadoun A, Hoyt RF Jr, Fruchart-Najib J, Madj Z, Brewer HB Jr, Santamarina-Fojo S: In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL. Arterioscler Thromb Vasc Biol 20: 793-800, 2000.
92. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW: Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13: 720-728, 1993.
93. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ: A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21: 424-428, 1999.
94. Hirata K, Dichek HL, Cioffi JA, Choi SY, Leeper NJ, Quintana L, Kronmal GS, Cooper AD, Quertermous T: Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem 274: 14170-14175, 1999.
95. Cilingiroglu M, Ballantyne C: Endothelial lipase and cholesterol metabolism. Curr Atheroscler Rep 6: 126-130, 2004.
96. Ishida T, Choi SY, Kundu RK, Spin J, Yamashita T, Hirata K, Kojima Y, Yokoyama M, Cooper AD, Quertermous T: Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 279: 45085-45092, 2004.
97. Mank-Seymour AR, Durham KL, Thompson JF, Seymour AB, Milos PM: Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels. Biochim Biophys Acta 1636: 40-46, 2004.
98. Yancey PG, Kawashiri MA, Moore R, Glick JM, Williams DL, Connelly MA, Rader DJ, Rothblat GH: In vivo modulation of HDL phospholipid has opposing effects on SR-BI-and ABCA1-mediated cholesterol efflux. J Lipid Res 45: 337-346, 2004.
99. Gauster M, Oskolkova OV, Innerlohinger J, Glatter O, Knipping G, Frank S: Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux. Biochem J 382: 75-82, 2004.
100. Bays H, Stein EA: Pharmacotherapy for dyslipidaemia-current therapies and future agents. Expert Opin Pharmacother 4: 1901-1938, 2003.
101. Sacks FM: The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 90: 139-143, 2002.
102. Kashyap ML, Tavintharan S, Kamanna VS: Optimal therapy of low levels of high density lipoprotein-cholesterol. Am J Cardiovasc Drugs 3: 53-65, 2003.
103. Mardones P, Altay M, Miquel JF, Rigotti A, Pilon A, Bouly M, Duran D, Luc G, Clavey V, Staels B, Nishimoto T, Arai H, Kozarsky KF: Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem 278: 7884-7890, 2003.
104. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R: Effect of recombinant apoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290: 2292-2300, 2003.
105. Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, Magnus-Aryitey G, Cosgrove PG, Sand TM, Wester RT, Williams JA, Perlman ME, Bamberger MJ: Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 24: 490-497, 2004.
106. de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA: The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. J Am Coll Cardiol 43: 854-857, 2004.
107. Burgess JW, Neville TA, Rouillard P, Harder Z, Beanlands DS, Sparks DL: Phosphatidylinositol increases HDL-C levels in humans. J Lipid Res 46: 350-355, 2005.
108. Morgan JM, Carey CM, Lincoff A, Capuzzi DM: The effects of niacin on lipoprotein subclass distribution. Prev Cardiol 7: 182-187, 2004.
109. Mittendorfer B, Ostlund RE Jr, Patterson BW, Klein S: Orlistat inhibits dietary cholesterol absorption. Obes Res 9: 599-604, 2001.
110. Davidson MH, Dillon MA, Gordon B, Jones P, Samuels J, Weiss S, Isaacsohn J, Toth P, Burke SK: Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 159: 1893-1900, 1999.
111. Altmann SW, Davis HR Jr, Yao X, Laverty M, Compton DS, Zhu LJ, Crona JH, Caplen MA, Hoos LM, Tetzloff G, Priestley T, Burnett DA, Strader CD, Graziano MP: The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta 1580: 77-93, 2002.